Vimarsana
Biggest News Aggregation in the World

Page 3 - Current Management News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Current Management. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Current Management Today - Breaking & Trending Today

Mallinckrodt Presents Clinical Data for TERLIVAZ® (terlipressin) for Injection in Adults with Hepatorenal Syndrome (HRS) at the American Transplant Congress (ATC) 2023 - Vimarsana News

Mallinckrodt Presents Clinical Data for TERLIVAZ® (terlipressin) for Injection in Adults with Hepatorenal Syndrome (HRS) at the American Transplant Congress (ATC) 2023

Published: June 1, 2023

/PRNewswire/ -- Mallinckrodt plc (NYSE American: MNK), a global specialty pharmaceutical company, today announced the presentation of results from two clinical...

Source: prnewswire.com
Related Topics:
United StatesSan DiegoTufts Medical CenterFredric GordonDerek BelzKhurram JamilClin TransplHeather GuzziRyan TaylorDanielj SpecialePrashant PandyaUnited States Census BureauClinical Development Critical Care At MallinckrodtUniversity Of Wisconsin HospitalAmerican College Of GastroenterologyNational Organization For Rare DisordersExchange CommissionAmerican Transplant CongressMallinckrodt Hospital Products IncMallinckrodt PharmaceuticalsGreen Room CommunicationsImportant Safety InformationBoxed WarningAmerican AssociationLiver Diseases
Mallinckrodt Presents Clinical Data for TERLIVAZ® (terlipressin) for Injection in Adults with Hepatorenal Syndrome (HRS) at Digestive Disease Week (DDW) 2023 - Vimarsana News

Mallinckrodt Presents Clinical Data for TERLIVAZ® (terlipressin) for Injection in Adults with Hepatorenal Syndrome (HRS) at Digestive Disease Week (DDW) 2023

Published: May 8, 2023

/PRNewswire/ -- Mallinckrodt plc (NYSE American: MNK), a global specialty pharmaceutical company, today announced the presentation of results from two clinical...

Source: prnewswire.com
Related Topics:
United StatesUnited KingdomKhurram JamilDerek BelzJasmohans BajajPeter RichardsonPrashant PandyaHeather GuzziKevin KorenblatRyan TaylorDanielj SpecialeMallinckrodt PharmaceuticalsAmerican College Of GastroenterologyNational Organization For Rare DisordersGreen Room CommunicationsExchange CommissionMallinckrodt Hospital Products IncSchool Of Internal MedicineClinical Development Critical Care At MallinckrodtSociety For Surgery Of The Alimentary TractWashington University School Of MedicineAmerican Society For Gastrointestinal EndoscopyVirginia Commonwealth UniversityAmerican Gastroenterological AssociationUnited States Census Bureau
Mallinckrodt Recognized as Industry Innovator at National Organization for Rare Disorders (NORD) 2023 Rare Impact Awards - Vimarsana News

Mallinckrodt Recognized as Industry Innovator at National Organization for Rare Disorders (NORD) 2023 Rare Impact Awards

Published: May 5, 2023

/PRNewswire/ -- Mallinckrodt plc (NYSE American: MNK), a global specialty pharmaceutical company, is pleased to announce it has received an award from the...

Source: prnewswire.com
Related Topics:
United StatesUnited KingdomPrnewswire MallinckrodtPrashant PandyaRyan TaylorDerek BelzPeter RichardsonDanielj SpecialeHeather GuzziExchange CommissionDrug AdministrationGreen Room CommunicationsUnited States Census BureauMallinckrodt Hospital Products IncNational Organization For Rare DisordersMallinckrodt PharmaceuticalsNational OrganizationRare DisordersHepatorenal SyndromeImportant Safety InformationBoxed WarningExecutive Vice PresidentChief Scientific OfficerImpact AwardsRare Impact Awards
Significant Positive Shift in the Glioma Market with 13% CAGR During the Study Period (2019-2032) Expected by Analysts at DelveInsight - Vimarsana News

Significant Positive Shift in the Glioma Market with 13% CAGR During the Study Period (2019-2032) Expected by Analysts at DelveInsight

Published: May 1, 2023

/PRNewswire/ -- DelveInsight's Glioma Market Insights report includes a comprehensive understanding of current treatment practices, glioma emerging drugs,...

Source: prnewswire.com
Related Topics:
United KingdomUnited StatesAvastin GenentechDaiichi SankyoShruti ThakurOlaptesed PegolTemodar Temodal MerckEli LillyDenovo BiopharmaLaminar PharmaceuticalsMarket ResearchLee PharmaceuticalClinical DevelopmentKey Glioma CompaniesRoche Incyte CorporationOblato IncEuropean Association Of NeuroAmerican Society Of Therapeutic RadiologyEpitopoietic Research CorporationIncyte CorporationInovio PharmaceuticalsHealthcare ServicesKey CompaniesAmerican Society Of Clinical OncologyDelmar Pharmaceuticals
Mallinckrodt to Present Data on TERLIVAZ® (terlipressin) for Injection in Adult Patients with Hepatorenal Syndrome (HRS) at the National Kidney Foundation (NKF) 2023 Spring Clinical Meeting (SCM) - Vimarsana News

Mallinckrodt to Present Data on TERLIVAZ® (terlipressin) for Injection in Adult Patients with Hepatorenal Syndrome (HRS) at the National Kidney Foundation (NKF) 2023 Spring Clinical Meeting (SCM)

Published: April 10, 2023

/PRNewswire/ -- Mallinckrodt plc (NYSE American: MNK), a global specialty pharmaceutical company, today announced that two scientific abstracts on the clinical...

Source: prnewswire.com
Related Topics:
United StatesRyan TaylorDerek BelzXingyue HuangMuhammad Ahmad MujtabaPrashant PandyaMuhammada MujtabaPrnewswire MallinckrodtDanielj SpecialeKhurram JamilHeather GuzziClinical Development Critical CareMallinckrodt PharmaceuticalsExchange CommissionAustin Convention CenterUnited States Census BureauNational Kidney FoundationMallinckrodt Hospital Products IncGreen Room CommunicationsUniversity Of Texas Medical BranchNational Organization For Rare DisordersClinical MeetingImportant Safety InformationBoxed WarningSenior Director